Mangoceuticals, Total Assets from 2010 to 2025

MGRX Stock

4.46 0.11 2.53%

Mangoceuticals, Common Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

15.4 M

Current Value

16.1 M

Quarterly Volatility

5.3 M

Credit Downgrade

Yuan Drop

Covid

Check Mangoceuticals, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangoceuticals, Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.4 K, Interest Expense of 14.4 K or Selling General Administrative of 3.2 M, as well as many indicators such as Price To Sales Ratio of 9.61, Dividend Yield of 0.14 or PTB Ratio of 0.36. Mangoceuticals, financial statements analysis is a perfect complement when working with Mangoceuticals, Common Valuation or Volatility modules.

Check out the analysis of Mangoceuticals, Common Correlation against competitors.

Latest Mangoceuticals, Common's Total Assets Growth Pattern

Below is the plot of the Total Assets of Mangoceuticals, Common Stock over the last few years. Total assets refers to the total amount of Mangoceuticals, Common assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Mangoceuticals, Common books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Mangoceuticals, Common's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mangoceuticals, Common's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 15.37 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Mangoceuticals, Total Assets Regression Statistics

	Arithmetic Mean	2,114,639
	Geometric Mean	82,405
	Coefficient Of Variation	252.39
	Mean Deviation	3,410,034
	Median	22,550
	Standard Deviation	5,337,233
	Sample Variance	28.5T
	Range	16.1M
	R-Value	0.61
	Mean Square Error	19.3T
	R-Squared	0.37
	Significance	0.01
	Slope	678,541
	Total Sum of Squares	427.3T

Mangoceuticals, Total Assets History

	2025	16.1 M
	2024	15.4 M
	2023	1.1 M
	2022	1 M

Other Fundumenentals of Mangoceuticals, Common

Intangibles To Total Assets

Mangoceuticals, Common Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Accounts Payable	Property Plant Equipment	Intangible Assets
Total Assets		1.0	0.76	0.33	-0.94	0.99	0.66	0.62	-0.01	0.72	0.68	0.7	-0.46	0.73	-0.95	-0.95
Total Stockholder Equity	1.0		0.75	0.34	-0.94	0.99	0.65	0.61	-0.02	0.71	0.67	0.7	-0.47	0.73	-0.95	-0.95
Net Tangible Assets	0.76	0.75		-0.33	-0.88	0.85	0.97	0.95	0.63	0.9	0.96	0.86	0.17	0.81	-0.69	-0.69
Net Debt	0.33	0.34	-0.33		-0.02	0.21	-0.43	-0.45	-0.93	-0.33	-0.42	-0.1	-0.98	-0.23	-0.37	-0.37
Retained Earnings	-0.94	-0.94	-0.88	-0.02		-0.95	-0.81	-0.78	-0.26	-0.89	-0.85	-0.69	0.15	-0.91	0.86	0.86
Total Liab	0.99	0.99	0.85	0.21	-0.95		0.76	0.72	0.13	0.78	0.77	0.79	-0.36	0.76	-0.93	-0.93
Net Invested Capital	0.66	0.65	0.97	-0.43	-0.81	0.76		1.0	0.72	0.93	0.99	0.87	0.28	0.82	-0.53	-0.53
Short Long Term Debt	0.62	0.61	0.95	-0.45	-0.78	0.72	1.0		0.72	0.94	0.99	0.86	0.3	0.82	-0.46	-0.46
Total Current Assets	-0.01	-0.02	0.63	-0.93	-0.26	0.13	0.72	0.72		0.57	0.68	0.45	0.84	0.42	0.07	0.07
Capital Stock	0.72	0.71	0.9	-0.33	-0.89	0.78	0.93	0.94	0.57		0.98	0.73	0.21	0.97	-0.55	-0.55
Net Working Capital	0.68	0.67	0.96	-0.42	-0.85	0.77	0.99	0.99	0.68	0.98		0.82	0.27	0.9	-0.53	-0.53
Short Term Debt	0.7	0.7	0.86	-0.1	-0.69	0.79	0.87	0.86	0.45	0.73	0.82		-0.08	0.56	-0.57	-0.57
Common Stock	-0.46	-0.47	0.17	-0.98	0.15	-0.36	0.28	0.3	0.84	0.21	0.27	-0.08		0.14	0.49	0.49
Accounts Payable	0.73	0.73	0.81	-0.23	-0.91	0.76	0.82	0.82	0.42	0.97	0.9	0.56	0.14		-0.58	-0.58
Property Plant Equipment	-0.95	-0.95	-0.69	-0.37	0.86	-0.93	-0.53	-0.46	0.07	-0.55	-0.53	-0.57	0.49	-0.58		1.0
Intangible Assets	-0.95	-0.95	-0.69	-0.37	0.86	-0.93	-0.53	-0.46	0.07	-0.55	-0.53	-0.57	0.49	-0.58	1.0

Click cells to compare fundamentals

About Mangoceuticals, Common Financial Statements

Mangoceuticals, Common investors use historical fundamental indicators, such as Mangoceuticals, Common's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mangoceuticals, Common. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	15.4 M	16.1 M
Intangibles To Total Assets	0.89	0.79

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Mangoceuticals, Stock Analysis

When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC